Ilex Medical Ltd / Fundamentals
Income statement
- Net revenue
€238.15M - Cost of goods sold
€182.90M - Gross profit
€55.25M - SG&A expenses
€4.48M - R&D expenses
€1.73M - EBITDA
€31.36M - D&A
€12.80M - EBIT
€16.40M - Interest expenses
€343.83K - EBT
€18.40M - Tax expenses
€4.85M - Net income
€11.82M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€431.14K - Changes in working capital
-€14.63M - Operating cash flow
€15.26M - Capex
€7.54M - Other investing cash flow
€10.27M - Net investing cash flow
-€9.53M - Total cash dividends paid
-€3.53M - Issuance of common stock
€0.00 - Debt repayment
-€107.53K - Other financing cash flow
-€3.44M - Net financing cash flow
-€7.08M - Foreign exchange effects
-€512.24K - Net change in cash
-€1.86M - Cash at end of period
€48.39M - Free cash flow
€22.81M
Balance sheet
- Cash and cash equivalents
€48.39M - Cash and short-term investments
€63.90M - Total receivables
€67.78M - Inventory
€39.70M - Other current assets
€3.61M - Total current assets
€174.99M - Property, plant & equipment
€38.57M - Goodwill
€1.82M - Intangible assets
€3.52M - Long-term investments
€0.00 - Other non-current assets
€24.96M - Total non-current assets
€70.45M - Total assets
€245.43M - Accounts payable
€24.91M - Short-term debt
€3.36M - Other current liabilities
€26.72M - Total current liabilities
€56.62M - Long-term debt
€8.74M - Deferred tax liabilities
€484.52K - Other non-current liabilities
€2.97M - Total non-current liabilities
€17.71M - Total liabilities
€74.34M - Common stock
€3.23M - Retained earnings
€150.53M - Other equity
€0.00 - Total equity
€171.10M - Total liabilities and shareholders' equity
€245.43M
Company information
- Market capitalization
€693.44M - Employees
178 - Enterprise Value
€555.56M
Company ratios
- Gross margin
-
23.2% Worse than peer group: 29.3% - EBITDA margin
-
13.2% Even with peer group: 11.2% - EBIT margin
-
6.9% Even with peer group: 8.2% - EBT margin
-
7.7% Even with peer group: 7.4% - Net margin
-
5.0% Even with peer group: 5.6% - ROE
-
6.9% Worse than peer group: 25.6% - ROA
-
4.8% Even with peer group: 7.8% - Asset turnover
-
97.0% Much worse than peer group: 155.3% - FCF margin
-
3.2% Even with peer group: 7.0% - FCF yield
1.1% - Efficiency ratio
86.8% - Net sales per employee
-
€1.34M - Net income per employee
-
€66.39K